Skip to main content

Table 4 Prevalence estimates of Ascaris infection, according to a priori-defined subgroups and socio-demographic geographic parameters

From: Global prevalence of Ascaris infection in humans (2010–2021): a systematic review and meta-analysis

Variable:

Subgroup

Number datasets

Number of people screened (total)

Number of test positive people

Pooled prevalence, % (95% CI)

Prevalence ratio, % (95% CI)

Type of population

 Children

494

969,034

112,608

13.50 (12.39–14.65)

8.82 (8.73–8.91)

 Adult

8

8479

290

8.85 (1.53–20.25)

2.59 (2.31–2.90)

 Total population

256

3,946,363

51,981

6.89 (6.19–7.63)

1

Gender

 Male

138

477,521

22,559

14.61 (12.64–16.68)

1

 Female

138

417,804

22,260

14.67 (12.61–16.86)

1.12 (1.10–1.14)

Residence

 Urban

143

75,535

6222

10.02 (7.29–13.12)

1

 Rural

143

118,029

17,341

17.33 (14.21–20.69)

1.78 (1.73–1.83)

Age, years

 ≤ 5

51

17,863

2192

15.19 (10.69–20.29)

1.97 (1.87–2.07)

 6–11

50

64,428

4008

15.96 (11.68–20.74)

1

 12–18

71

176,149

23,029

14.14 (11.67–16.80)

2.10 (2.03–2.17)

 19–30

9

7538

1373

19.52 (9.55–31.65)

2.92 (2.76–3.09)

 31–50

5

2323

637

22.53 (8.93–39.94)

4.40 (4.09–4.74)

 ≥ 51

4

1467

378

25.82 (23.59–28.12)

4.14 (3.77–4.54)

Diagnostic method used

 Routine parasitological methodsa

353

3,207,496

43,680

9.22 (8.45–10.01)

1

 Kato-Katz

368

1,693,547

117,567

12.68 (11.40–14.01)

5.09 (5.04–5.15)

 Othersb

37

22,833

3275

11.90 (7.29–17.43)

10.53 (10.19–10.88)

Income

 Low

153

473,915

59,829

13.23 (11.64–14.91)

5.34 (5.15–5.54)

 Lower middle

385

1,072,320

77,869

12.17 (10.89–13.52)

3.07 (2.96–3.19)

 Upper middle

178

3,252,040

24,217

9.97 (9.14–10.83)

0.31 (0.30–0.32)

 High

42

125,601

2964

0.88 (0.33–1.64)

1

Human development index (HDI)

 Low

273

583,335

70,802

12.31 (11.01–13.67)

5.64 (5.51–5.77)

 Medium

210

2,524,185

43,210

11.71 (10.24–13.25)

0.79 (0.77–0.81)

 High

190

1,444,298

42,864

11.45 (10.17–12.79)

1.37 (1.34–1.41)

 Very high

85

372,058

8003

5.01 (3.90–6.25)

1

Risk of bias

 Low

378

4,405,898

139,663

7.81 (6.94–8.73)

1

 Moderate

269

477,606

21,430

14.28 (12.68–15.96)

1.41 (1.39–1.43)

 High

111

40,372

3786

16.23 (12.77–20.02)

2.95 (2.86–3.05)

Year of publication

 2010–2013

206

513,557

24,369

9.18 (7.87–10.58)

2.24 (2.20–2.27)

 2014–2017

300

1,221,037

73,006

12.61 (11.15–14.15)

2.82 (2.79–2.85)

 2018–2021

252

3,189,282

67,504

10.73 (9.57–11.95)

1

Year of start sampling

 Before 2010

197

1,500,014

39,518

8.52 (7.57–9.53)

1

 2010–2015

412

2,862,290

108,649

12.59 (11.22–14.02)

1.44 (1.42–1.45)

 2016–2021

149

561,572

16,712

10.24 (8.53–12.09)

1.12 (1.10–1.14)

Year of end sampling

 Before 2010

150

504,076

28,385

9.91 (8.21–11.74)

2.04 (2.01–2.07)

 2010–2015

413

3,390,700

108,179

12.15 (11.01–13.34)

1.15 (1.14–1.17)

 2016–2021

195

1,029,100

28,315

9.57 (8.42–10.79)

1

  1. CI, confidence interval
  2. aDirect wet mount, Formalin-ether and other routine sedimentation or concentration methods
  3. bMcMaster, Lumbreras rapid sedimentation, Lutz’s (sedimentation) technique, FLOTAC, Mini-FLOTAC, Polymerase chain reaction (PCR), Ritchie, Stoll’s dilution egg count